Surfactant protein D in Pseudomonas aeruginosa keratitis

Ocular Immunology and Inflammation

Volumn 15, Issue 5, 2007, Pages 371-379

  McCormick, C C ^a,b   Hobden, J A ^a   Balzli, C L ^b   Reed, J M ^a,b   Caballero, A R ^a,b   Denard, B S ^a   Tang, A ^b   O'Callaghan, R J ^a,b,c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Genetically deficient mice; Keratitis; Pseudomonas aeruginosa; Surfactant protein D

Indexed keywords

SURFACTANT PROTEIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED STUDY; CORNEA; HOST RESISTANCE; IMMUNOBLOTTING; KERATITIS; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SLIT LAMP; WILD TYPE;

ANIMALS; CORNEA; IMMUNOBLOTTING; KERATITIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; TIME FACTORS;

EID: 35648999025     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940701486423     Document Type: Article

References (44)

1. Alcorn JF, Wright JR. Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J Biol Chem. 2004;279:30871-30879.
2. Awasthi S, Coalson JJ, Yoder BA, et al. Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons. Am J Respir Crit Care Med. 2001;163:389-397.
3. Beatty AL, Malloy JL, Wright JR. Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro. Am J Respir Cell Mol Biol. 2005;32:128-134.
4. Beisel KW, Hazlett LD, Berk RS. Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa. Proc Soc Exp Biol Med. 1983;172:488-491.
5. Berk RS, Beisel K, Hazlett LD. Genetic studies of the murine corneal response to Pseudomonas aeruginosa. Infect Immun. 1981;34:1-5.
6. Berk RS, Hazlett LD. Further studies on the genetic control of murine corneal response to Pseudomonas aeruginosa. Rev Infect Dis. 1983;5(Suppl 5):S936-S940.
7. Bourcier T, Thomas F, Borderie V, et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87:834-838.
8. Bruinsma GM, Rustema-Abbing M, de Vries J, et al. Influence of wear and overwear on surface properties of etafilcon A contact lenses and adhesion of Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 2002;43:3646-3653.
9. Bufler P, Schikor D, Schmidt B, et al. Cytokine stimulation by Pseudomonas aeruginosa - strain variation and modulation by pulmonary surfactant. Exp Lung Res. 2004;30:163-179.
10. Bufler P, Schmidt B, Schikor D, et al. Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol. 2003;28:249-256.
11. Cleveland RP, Hazlett LD, Leon MA, et al. Role of complement in murine corneal infection caused by Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 1983;24:237-242.
12. Coyle PK, Sibony PA, Johnson C. Electrophoresis combined with immunologic identification of human tear proteins. Invest Ophthalmol Vis Sci. 1989;30:1872-1878.
13. Crouch EC. Modulation of host-bacterial interactions by collectins. Am J Respir Cell Mol Biol. 1999;21:558-561.
14. Crouch EC. Surfactant protein-D and pulmonary host defense. Respir Res. 2000;1:93-108.
15. Engel LS, Hobden JA, Moreau JM, et al. Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest Ophthalmol Vis Sci. 1997;38:1535-1542.
16. Faure K, Leberre R, Guery B. Pseudomonas aeruginosa and surfactant-associated proteins A and D. Med Mal Infect. 2006;36:63-71.
17. Fleiszig SM, Kwong MS, Evans DJ. Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid. Infect Immun. 2003;71:3866-3874.
18. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun. 1997;65:579-586.
19. Fleiszig SM, Zaidi TS, Preston MJ, et al. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1996;64:2288-2294.
20. Giannoni E, Sawa T, Allen L, et al. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol. 2006;34:704-710.
21. Girgis DO, Sloop GD, Reed JM, et al. A new topical model of Staphylococcus corneal infection in the mouse. Invest Ophthalmol Vis Sci. 2003;44:1591-1597.
22. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996;60:539-574.
23. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res. 2004;23:1-30.
24. Korfhagen TR., Sheftelyevich V, Burhans MS, et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem. 1998;273:28438-28443.
25. Kwon B, Hazlett LD. Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol. 1997;159:6283-6290.
26. Levine AM, Whitsett JA. Pulmonary collectins and innate host defense of the lung. Microbes Infect. 2001;3:161-166.
27. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000;2:1051-1060.
28. Madan T, Reid KB, Singh M, et al. Susceptibility of mice genetically defi-cient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus. J Immunol. 2005;174:6943-6954.
29. Mah-Sadorra JH, Yavuz SG, Najjar DM, et al. Trends in contact lens-related corneal ulcers. Cornea. 2005;24:51-58.
30. Malloy JL, Veldhuizen RA, Thibodeaux BA, et al. Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol. 2005;288:L409-L418.
31. McNamara NA, Andika R, Kwong M, et al. Interaction of Pseudomonas aeruginosa with human tear fluid components. Curr Eye Res. 2005;30:517-525.
32. Motwani M, White RA, Guo N, et al. Mouse surfactant protein-D. cDNA cloning, characterization, and gene localization to chromosome 14. J Immunol. 1995;155:5671-5677.
33. Nakamura T, Takahashi H. Screening of antibiotics resistance to Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii by an advanced expert system. J Infect Chemother. 2005;11:288-292.
34. Ni M, Evans DJ, Hawgood S, et al. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun. 2005;73:2147-2156.
35. Noah TL, Murphy PC, Alink JJ, et al. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med. 2003;168:685-691.
36. O'Callaghan RJ. Role of exoproteins in bacterial keratitis: the Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, November 7, 1998. Cornea. 1999;18:532-537.
37. O'Callaghan RJ, Engel LS, Hobden JA, et al. Pseudomonas keratitis: the role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci. 1996;37:534-543.
38. Pandey A, Malenie R, Asthana AK. Beta-lactamase producing Pseudomonas aeruginosa in hospitalised patients. Indian J Pathol Microbiol. 2005;48:530-533.
39. Qu XD, Lehrer RI. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun. 1998;66:2791-2797.
40. Restrepo CI, Dong Q, Savov J, et al. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol. 1999;21:576-585.
41. Schmut O, Horwath-Winter J, Zenker A, et al. The effect of sample treatment on separation profiles of tear fluid proteins: qualitative and semi-quantitative protein determination by an automated analysis system. Graefes Arch Clin Exp Ophthalmol. 2002;240:900-905.
42. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000;406:959-964.
43. Wilmott R, Fiedler M, Stark JM. (1998). Host defense mechanisms. In Chernick V, Boat T (eds.), Disorders in the respiratory tract of children (pp. 238-264). Philadelphia, PA: WB Saunders.
44. Wu H, Kuzmenko A, Wan S, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest. 2003;111:1589-1602.